[
    [
        {
            "time": "2023-10-16",
            "original_text": "医药周报：板块回暖 新冠疫苗信息更新带动疫苗板块表现强势",
            "features": {
                "keywords": [
                    "医药",
                    "疫苗",
                    "板块回暖",
                    "新冠疫苗",
                    "信息更新"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药周报：板块回暖 新冠疫苗信息更新带动疫苗板块表现强势",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "医药生物行业：第二款国产新冠疫苗获批上市 看好疫苗大时代背景下的新冠增量",
            "features": {
                "keywords": [
                    "医药生物",
                    "国产新冠疫苗",
                    "获批上市",
                    "疫苗大时代",
                    "新冠增量"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业：第二款国产新冠疫苗获批上市 看好疫苗大时代背景下的新冠增量",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-16",
            "original_text": "医药行业周报：第四批集采落地 持续看好创新及相关产业链CXO",
            "features": {
                "keywords": [
                    "医药行业",
                    "第四批集采",
                    "落地",
                    "创新",
                    "CXO"
                ],
                "sentiment_score": 0.65,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "CXO"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业周报：第四批集采落地 持续看好创新及相关产业链CXO",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]